HealthCare Global Enterprises Limited

NSEI:HCG Stok Raporu

Piyasa değeri: ₹65.6b

HealthCare Global Enterprises Gelecekteki Büyüme

Future kriter kontrolleri 4/6

HealthCare Global Enterprises kazanç ve gelirin sırasıyla yıllık 42.8% ve 13.3% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 45.9% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 12.5% olacağı tahmin edilmektedir.

Anahtar bilgiler

42.8%

Kazanç büyüme oranı

45.9%

EPS büyüme oranı

Healthcare kazanç büyümesi26.9%
Gelir büyüme oranı13.3%
Gelecekteki özkaynak getirisi12.5%
Analist kapsamı

Good

Son güncelleme08 Oct 2024

Gelecekteki son büyüme güncellemeleri

HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

Feb 11
HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

Recent updates

We Take A Look At Why HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation Is Well Earned

Sep 19
We Take A Look At Why HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation Is Well Earned

HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

Feb 11
HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation

Sep 14
We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation

A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)

Sep 05
A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)

HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price

May 17
HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price

Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?

Jun 24
Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?

Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings

Jun 03
Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings

Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?

Dec 08
Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?

What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?

Jun 25
What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?

Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares

Mar 14
Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares

The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On

Mar 03
The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On

Here's Why HealthCare Global Enterprises (NSE:HCG) Can Afford Some Debt

Jan 27
Here's Why HealthCare Global Enterprises (NSE:HCG) Can Afford Some Debt

How Many HealthCare Global Enterprises Limited (NSE:HCG) Shares Did Insiders Buy, In The Last Year?

Dec 23
How Many HealthCare Global Enterprises Limited (NSE:HCG) Shares Did Insiders Buy, In The Last Year?

Kazanç ve Gelir Büyüme Tahminleri

NSEI:HCG - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (INR Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
3/31/202729,1892,206N/AN/A2
3/31/202625,0971,2071,557N/A9
3/31/202522,291745-294N/A8
6/30/202419,770526N/AN/AN/A
3/31/202419,1214829892,846N/A
12/31/202318,592353N/AN/AN/A
9/30/202318,1403719222,197N/A
6/30/202317,471309N/AN/AN/A
3/31/202316,9442931,1842,516N/A
12/31/202216,174270N/AN/AN/A
9/30/202215,507-2641,1562,364N/A
6/30/202214,827694N/AN/AN/A
3/31/202213,9785371,4892,201N/A
12/31/202113,312-544N/AN/AN/A
9/30/202112,472-3791,0891,510N/A
6/30/202111,431-1,633N/AN/AN/A
3/31/202110,134-1,9358511,205N/A
12/31/20209,858-1,349N/AN/AN/A
9/30/20209,897-1,2847511,271N/A
6/30/202010,202-1,284N/AN/AN/A
3/31/202010,956-1,0672231,301N/A
12/31/201910,832-718N/AN/AN/A
9/30/201910,541-552N/AN/AN/A
6/30/201910,210-394N/AN/AN/A
3/31/20199,787-248-903985N/A
12/31/20189,430-135N/AN/AN/A
9/30/20189,004-41N/AN/AN/A
6/30/20188,661124N/AN/AN/A
3/31/20188,307205N/A978N/A
12/31/20177,909257N/AN/AN/A
9/30/20177,608278N/AN/AN/A
6/30/20177,237219N/AN/AN/A
3/31/20177,001230N/A913N/A
12/31/20166,705208N/AN/AN/A
9/30/20166,392133N/AN/AN/A
6/30/20166,08167N/AN/AN/A
3/31/20165,842-178N/A732N/A
12/31/20155,611-33N/AN/AN/A
9/30/20155,4949N/A763N/A
6/30/20155,3239N/AN/AN/A
3/31/20155,1948N/A597N/A
3/31/20144,513-356N/A514N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: HCG 'nin tahmini kazanç büyümesi (yıllık 42.8% ) tasarruf oranının ( 6.7% ) üzerindedir.

Kazançlar ve Piyasa: HCG şirketinin kazançlarının (yıllık 42.8% ) Indian pazarından (yıllık 17.9% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: HCG şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: HCG şirketinin gelirinin (yıllık 13.3% ) Indian pazarından (yıllık 10.3% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: HCG şirketinin gelirinin (yıllık 13.3% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: HCG 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 12.5 %).


Büyüyen şirketleri keşfedin